Engineered Enzyme Eliminates Nicotine Addiction in Preclinical Tests
PIEZO2, a Molecular Target for Treating Clinical Pain
If you’ve ever been sunburned, you’ve experienced the dreaded pain of putting on a shirt the next day. Fabric that should feel soft turns into a layer of painful pressure. That kind of pain-from what should feel like a gentle touch-is called allodynia, and it’s a fact of life for many people who suffer from…
Transforming Pregnancy Research With a Smartphone App
New Urine Dipstick Test Detects Cause of Disease That Blinds Millions
Scientists Create Atomic Glue Gun to Build Better Nucleic Acid Therapeutics
‘Click Chemistry’ Reactions May Boost Cancer-Fighting Drug Potency
‘Double Decker’ Antibody Technology Fights Cancer
TSRI Researchers Join National Digital Health Informatics Collaborative
Study Reveals New Clues to How a Successful HIV Vaccine Could Work
At Last, a Clue to Where Cancer Metastases Are Born
Surprising Brain Change Appears to Drive Alcohol Dependence
Experimental Small Molecule Shows Potential in Treating Meth Relapse
A Molecular On/Off Switch for CRISPR
Picture bacteria and viruses locked in an arms race. For many bacteria, one line of defense against viral infection is a sophisticated RNA-guided “immune system” called CRISPR-Cas. At the center of this system is a surveillance complex that recognizes viral DNA and triggers its destruction. However, viruses can strike back and disable this surveillance complex…
New Class of Anti-Diabetes Compounds Discovered that Reduce Liver Glucose Production
Researchers Discover Key to Drug Resistance in Common Breast Cancer Treatment
Scientists Show Deep Brain Stimulation May Block Heroin Relapse
Scripps Team Awarded $1.8M Grant to Develop Drugs for Heart Disease, RA
Scientists Uncover New Way to Defeat Therapy-Resistant Prostate Cancer
Scientists Illuminate Key Molecular Player in Both Morphine Addiction and Rare Disease
Scientists Discover Antibodies That Target Holes in HIV’s Defenses
A new study from scientists at The Scripps Research Institute (TSRI) shows that “holes” in HIV’s defensive sugar shield could be important in designing an HIV vaccine. It appears that antibodies can target these holes, which are scattered in HIV’s protective sugar or “glycan” shield, and the question is now whether these holes can be…
Scientists Find Potential Treatment for ‘Painful Blindness’ Form of Dry Eye
Scientists Pinpoint Ebola’s Weak Spot
Scientists at The Scripps Research Institute (TSRI) now have a high-resolution view of exactly how the experimental therapy ZMapp targets Ebola virus. The new study is also the first to show how an antibody in the ZMapp “drug cocktail” targets a second Ebola virus protein, called sGP, whose vulnerable spots had previously been unknown. “This…